Hims & Hers Health, Inc. (HIMS): debt financing — Hims & Hers issues $1B 0% convertible notes due 2030; enters capped call transactions to reduce dilution

Hims & Hers Health, Inc.

$1.0B aggregate principal of 0.00% Convertible Senior Notes due 2030 issued May 13, 2025.
Initial conversion price ~$70.67 per share; conversion rate 14.1493 shares per $1,000 note.
Capped call transactions with initial cap price $89.95/share cost $47.8M to offset dilution on conversion.
Notes mature May 15, 2030; redeemable after May 19, 2028 if stock exceeds 130% of conversion price.
Initial purchasers' $130M option exercised in full on May 9, 2025, bringing total to $1.0B.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Hims & Hers Health, Inc. incurred convertible notes of $1.0 billion aggregate principal amount of Notes with U.S. Bank Trust Company, National Association at 0.00% maturing May 15, 2030.

Instrument: convertible notes
Principal: $1.0 billion aggregate principal amount of Notes
Counterparty: U.S. Bank Trust Company, National Association
Rate: 0.00%
Maturity: May 15, 2030
Event: incurrence

Exact text from the filing

On May 13, 2025, the Company issued $1.0 billion aggregate principal amount of Notes.

View on SEC.gov

73 debt financings filed in the last 30 days. Browse all debt financings →

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-118948

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.